Induced Pluripotent Stem Cells Market: By Technology (Cell Production, Cell Acquisition, Expansion and Sub-Culture, Cryopreservation, and Cryopreservation), By End User (Academic Institutions, Research Institutes, Biotechnology Companies, and Others), and Geography     

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Induced Pluripotent Stem Cells Market size was valued at USD 1678.54 million in 2021. It is expected to reach a value of USD 2876.72 million by 2028, growing at a CAGR of 8.0% from 2022-2028. Pluripotent stem cells are embryonic stem cells with the ability to develop into any adult cell type and aid in the repair of damaged tissues in the human body. Induced pluripotent stem cells, or iPSCs, are stem cells that have been genetically manipulated to act like pluripotent stem cells or embryonic stem cells. They can be collected from any tissue (typically skin or blood) from a child or an adult. The market for induced pluripotent stem cells is growing due to its ability to produce any cell or tissue the body requires. These cells can potentially be customised to provide a perfect genetic match for any patient suffering from diseases such as diabetes, spinal cord injury, leukaemia, or heart disease. Furthermore, these cells are really beneficial in comprehending. The report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Induced Pluripotent Stem Cells Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

Key Development:

In March 2015, FUJIFILM Holdings Corporation acquired Cellular Dynamics International, Inc.

Induced Pluripotent Stem Cells Market Summary

Study Period


Base Year




Largest Market


Fastest Growing Market

Induced Pluripotent Stem Cells Market Dynamics

The market for induced pluripotent stem cells (iPSCs) is driven by expanding adoption of stem cell therapies, a developing biotechnology sector with better funding, and the rising prevalence of chronic diseases. The wide range of clinical applications of induced pluripotent stem cells and increasing technological improvements of iPSCs are expected to boost the growth of the global induced pluripotent stem cells (iPSCs) market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Induced Pluripotent Stem Cells Market Segmentation

By Technology
  • Cell Production
  • Cell Acquisition
  • Expansion and Sub-Culture
  • Cryopreservation
By End User
  • Academic Institutions
  • Research Institutes
  • Biotechnology Companies
  • Others
By Geography
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Others
  • Asia Pacific
    • Japan
    • India
    • China
    • Others
    • Brazil
    • UAE
    • South Africa
    • Others


Frequently Asked Questions

The induced pluripotent stem cells market is projected to expand at a CAGR of 8.0% during the forecast period.

North America is the fastest-growing region for induced pluripotent stem cells market

Acelity Holdings, StemCells, Fujifilm Holding Corporation, Organogenesis Inc

[urltag url='request-table-of-content']

  • Acelity Holdings, Inc. (U.S)
  • StemCells, Inc. (U.S)
  • Japan Tissue Engineering Co., Ltd. (Japan)
  • Organogenesis Inc (U.S)
  • Fujifilm Holding Corporation (Japan)
  • Fate Therapeutics (U.S)
  • Bristol-Myers Squibb Company (U.S)